Published in Eur J Immunol on August 01, 2004
The intraepithelial T cell response to NKG2D-ligands links lymphoid stress surveillance to atopy. Science (2011) 1.78
Layer-by-layer-assembled multilayer films for transcutaneous drug and vaccine delivery. ACS Nano (2009) 1.75
The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res (2011) 1.69
Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy. J Allergy Clin Immunol (2011) 1.68
Mast cells in atopic dermatitis. Curr Opin Immunol (2009) 1.63
Skin barrier disruption: a requirement for allergen sensitization? J Invest Dermatol (2012) 1.40
Langerhans cells as targets for immunotherapy against skin cancer. Immunol Cell Biol (2010) 1.06
The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma. J Clin Cell Immunol (2014) 1.06
Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis. J Allergy Clin Immunol (2012) 1.05
Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations. J Allergy Clin Immunol (2014) 1.02
The tonsils revisited: review of the anatomical localization and histological characteristics of the tonsils of domestic and laboratory animals. Clin Dev Immunol (2011) 0.98
Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy. J Allergy Clin Immunol (2014) 0.96
Potential mechanisms for the association between fall birth and food allergy. Allergy (2012) 0.95
Intradermal immunization of mice with radiation-attenuated sporozoites of Plasmodium yoelii induces effective protective immunity. Malar J (2010) 0.93
The Role of TSLP in IL-13-induced atopic march. Sci Rep (2011) 0.92
Epicutaneous immunization converts subsequent and established antigen-specific T helper type 1 (Th1) to Th2-type responses. Immunology (2006) 0.90
Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations. Pharm Res (2010) 0.87
Topical vaccination: the skin as a unique portal to adaptive immune responses. Semin Immunopathol (2007) 0.86
Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year. J Allergy Clin Immunol (2015) 0.86
Epicutaneous immunization with type II collagen inhibits both onset and progression of chronic collagen-induced arthritis. PLoS One (2007) 0.85
Food allergy in children. Postgrad Med J (2005) 0.84
Cutting edge: persistence of increased mast cell numbers in tissues links dermatitis to enhanced airway disease in a mouse model of atopy. J Immunol (2011) 0.83
Use of animal models to investigate major allergens associated with food allergy. J Allergy (Cairo) (2013) 0.82
Transcutaneous vaccination via laser microporation. J Control Release (2012) 0.82
Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores. Vaccine (2012) 0.82
Filaggrin loss-of-function mutations are associated with food allergy in childhood and adolescence. J Allergy Clin Immunol (2014) 0.81
Low-frequency low-intensity ultrasounds do not influence the survival and immune functions of cultured keratinocytes and dendritic cells. J Biomed Biotechnol (2010) 0.79
Consensus Conference on Clinical Management of pediatric Atopic Dermatitis. Ital J Pediatr (2016) 0.78
Current challenges facing the assessment of the allergenic capacity of food allergens in animal models. Clin Transl Allergy (2016) 0.76
Mutations in the filaggrin gene and food allergy. Prz Gastroenterol (2014) 0.76
Influence of the route of exposure and the matrix on the sensitisation potency of a major cows' milk allergen. Clin Transl Allergy (2015) 0.75
Imaging CD4 T Cell Interstitial Migration in the Inflamed Dermis. J Vis Exp (2016) 0.75
IL-13 from intraepithelial lymphocytes regulates tissue homeostasis and protects against carcinogenesis in the skin. Nat Commun (2016) 0.75
Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. J Allergy Clin Immunol (2015) 2.82
Diversity of bifidobacteria within the infant gut microbiota. PLoS One (2012) 2.71
ICON: food allergy. J Allergy Clin Immunol (2012) 2.65
Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution. J Infect Dis (2011) 2.13
Phenotypic anchoring of gene expression changes during estrogen-induced uterine growth. Environ Health Perspect (2004) 1.84
Quantifying the development of the peripheral naive CD4+ T-cell pool in humans. Blood (2009) 1.79
Ranked prediction of p53 targets using hidden variable dynamic modeling. Genome Biol (2006) 1.78
Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit Care Med (2002) 1.68
Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol (2011) 1.62
Key issues for the assessment of the allergenic potential of genetically modified foods: breakout group reports. Environ Health Perspect (2003) 1.53
Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch Toxicol (2011) 1.46
Di-(2-ethylhexyl) phthalate is without adjuvant effect in mice on ovalbumin. Toxicology (2007) 1.44
Updating the skin sensitization in vitro data assessment paradigm in 2009. J Appl Toxicol (2009) 1.42
Measurement of peptide-specific IgE as an additional tool in identifying patients with clinical reactivity to peanuts. J Allergy Clin Immunol (2003) 1.35
A novel model of sensitization and oral tolerance to peanut protein. Immunology (2004) 1.35
Challenges and approaches for the development of safer immunomodulatory biologics. Nat Rev Drug Discov (2013) 1.35
Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods. Dermatitis (2005) 1.35
Epidermal Langerhans cell migration and sensitisation to chemical allergens. APMIS (2003) 1.25
Consensus report on the future of animal-free systemic toxicity testing. ALTEX (2014) 1.20
Quantifying thymic export: combining models of naive T cell proliferation and TCR excision circle dynamics gives an explicit measure of thymic output. J Immunol (2009) 1.20
Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study. PLoS Med (2013) 1.19
Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis. Infect Immun (2008) 1.16
Impaired Langerhans cell migration in psoriasis. J Exp Med (2006) 1.16
A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing - t4 report*. ALTEX (2012) 1.15
Human milk oligosaccharides reduce platelet-neutrophil complex formation leading to a decrease in neutrophil beta 2 integrin expression. J Leukoc Biol (2004) 1.13
Combining cytokine signalling with T-bet and GATA-3 regulation in Th1 and Th2 differentiation: a model for cellular decision-making. J Theor Biol (2004) 1.12
Immunogenicity of therapeutic proteins: influence of aggregation. J Immunotoxicol (2013) 1.10
Allergic contact dermatitis: is the reactive chemistry of skin sensitizers the whole story? Contact Dermatitis (2013) 1.09
Understanding the slow depletion of memory CD4+ T cells in HIV infection. PLoS Med (2007) 1.08
Neisseria meningitidis expressing lgtB lipopolysaccharide targets DC-SIGN and modulates dendritic cell function. Cell Microbiol (2006) 1.08
Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells. Immunology (2008) 1.08
Gene expression changes in peripheral blood-derived dendritic cells following exposure to a contact allergen. Toxicol Lett (2004) 1.05
The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses. J Immunol Methods (2006) 1.03
The need to decide if all estrogens are intrinsically similar. Environ Health Perspect (2004) 1.03
Dissection of a complex transcriptional response using genome-wide transcriptional modelling. Mol Syst Biol (2009) 1.01
Multivesicular bodies in intestinal epithelial cells: responsible for MHC class II-restricted antigen processing and origin of exosomes. Immunology (2008) 1.00
Differential regulation of epidermal langerhans cell migration by interleukins (IL)-1alpha and IL-1beta during irritant- and allergen-induced cutaneous immune responses. Toxicol Appl Pharmacol (2002) 1.00
Human dendritic cell activation by Neisseria meningitidis: phagocytosis depends on expression of lipooligosaccharide (LOS) by the bacteria and is required for optimal cytokine production. Cell Microbiol (2004) 0.99
Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. Blood (2002) 0.99
Reconstruction of cell population dynamics using CFSE. BMC Bioinformatics (2007) 0.99
From the top down: towards a predictive biology of signalling networks. Trends Biotechnol (2003) 0.99
IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis. J Leukoc Biol (2007) 0.98
Differential effects of interleukin-1 alpha and beta on interleukin-6 and chemokine synthesis in neurones. Mol Cell Neurosci (2008) 0.96
Regulation of expression of the novel IL-1 receptor family members in the mouse brain. J Neurochem (2005) 0.94
Influence of ageing on Langerhans cell migration in mice: identification of a putative deficiency of epidermal interleukin-1beta. Immunology (2002) 0.93
Luminal antigens access late endosomes of intestinal epithelial cells enriched in MHC I and MHC II molecules: in vivo study in Crohn's ileitis. Am J Physiol Gastrointest Liver Physiol (2007) 0.92
Mechanistic applicability domain classification of a local lymph node assay dataset for skin sensitization. Chem Res Toxicol (2007) 0.92
The effects of acute social stress on epidermal Langerhans' cell frequency and expression of cutaneous neuropeptides. J Invest Dermatol (2007) 0.92
Assessment of allergenic potential of genetically modified foods: an agenda for future research. Environ Health Perspect (2003) 0.92
Epicutaneous immunization converts subsequent and established antigen-specific T helper type 1 (Th1) to Th2-type responses. Immunology (2006) 0.90
Skin barrier dysfunction and systemic sensitization to allergens through the skin. Curr Drug Targets Inflamm Allergy (2005) 0.90
The expanding interleukin-1 family and its receptors: do alternative IL-1 receptor/signaling pathways exist in the brain? Mol Neurobiol (2003) 0.90
Fitting ordinary differential equations to short time course data. Philos Trans A Math Phys Eng Sci (2008) 0.90
Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals. Methods (2007) 0.89
New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI. J Proteome Res (2010) 0.89
Prediction of rodent nongenotoxic carcinogenesis: evaluation of biochemical and tissue changes in rodents following exposure to nine nongenotoxic NTP carcinogens. Environ Health Perspect (2002) 0.89
Interferon-gamma mediates antigen trafficking to MHC class II-positive late endosomes of enterocytes. Eur J Immunol (2005) 0.89
Antiretroviral therapy increases thymic output in children with HIV. AIDS (2014) 0.87
Langerhans cell mobilization distinguishes between early-onset and late-onset psoriasis. J Invest Dermatol (2010) 0.87
Induction of local innate immune responses and modulation of antigen uptake as mechanisms underlying the mucosal adjuvant properties of immune stimulating complexes (ISCOMS). Vaccine (2002) 0.87
Induction of iron homeostasis genes during estrogen-induced uterine growth and differentiation. Mol Cell Endocrinol (2006) 0.87
Mechanisms of interleukin-6 synthesis and release induced by interleukin-1 and cell depolarisation in neurones. Mol Cell Neurosci (2007) 0.87
Measurement of cytokine expression and Langerhans cell migration in human skin following suction blister formation. Exp Dermatol (2004) 0.87
Local lymph node data for the evaluation of skin sensitization alternatives: a second compilation. Dermatitis (2010) 0.86
Skin irritation, false positives and the local lymph node assay: a guideline issue? Regul Toxicol Pharmacol (2011) 0.85
A mouse model for food allergy using intraperitoneal sensitization. Methods (2007) 0.85
Correlation of allergen-specific IgG subclass antibodies and T lymphocyte cytokine responses in children with multiple food allergies. Pediatr Allergy Immunol (2010) 0.85
Identification of a truncated IL-18R beta mRNA: a putative regulator of IL-18 expressed in rat brain. J Neuroimmunol (2003) 0.85
Use of a B cell marker (B220) to discriminate between allergens and irritants in the local lymph node assay. Toxicol Sci (2002) 0.85
Epicutaneous immunization with type II collagen inhibits both onset and progression of chronic collagen-induced arthritis. PLoS One (2007) 0.85
The impact of LLNA group size on the identification and potency classification of skin sensitizers: a review of published data. Cutan Ocul Toxicol (2009) 0.85
Quantitative risk assessment for skin sensitisation: consideration of a simplified approach for hair dye ingredients. Regul Toxicol Pharmacol (2012) 0.85
Antigen targeting to MHC class II-enriched late endosomes in colonic epithelial cells: trafficking of luminal antigens studied in vivo in Crohn's colitis patients. FASEB J (2005) 0.85
The interleukin-1-related cytokine IL-1F8 is expressed in glial cells, but fails to induce IL-1beta signalling responses. Cytokine (2005) 0.84
Comparative analysis of skin sensitization potency of acrylates (methyl acrylate, ethyl acrylate, butyl acrylate, and ethylhexyl acrylate) using the local lymph node assay. Contact Dermatitis (2007) 0.84
Differential immunogenicity and allergenicity of native and recombinant human lactoferrins: role of glycosylation. Eur J Immunol (2012) 0.83
Assessment of glycosylation-dependent cell adhesion molecule 1 as a correlate of allergen-stimulated lymph node activation. Toxicology (2003) 0.83
Clonally diverse T cell homeostasis is maintained by a common program of cell-cycle control. J Immunol (2013) 0.83
Protein digestibility and relevance to allergenicity. Environ Health Perspect (2003) 0.83
Epstein-Barr virus can establish infection in the absence of a classical memory B-cell population. J Virol (2005) 0.82
A chemical dataset for evaluation of alternative approaches to skin-sensitization testing. Contact Dermatitis (2004) 0.82
Comparing antigen-independent mechanisms of T cell regulation. J Theor Biol (2004) 0.82
Chemical allergy: considerations for the practical application of cytokine profiling. Toxicol Sci (2003) 0.82
Identification of early molecular pathways affected by paraquat in rat lung. Toxicology (2006) 0.81
Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis. Pediatr Res (2003) 0.81
Danger, intracellular signaling, and the orchestration of dendritic cell function in skin sensitization. J Immunotoxicol (2012) 0.81
Gene regulation by IL-1beta independent of IL-1R1 in the mouse brain. Glia (2006) 0.81
Assessing the potency of respiratory allergens: uncertainties and challenges. Regul Toxicol Pharmacol (2011) 0.81
A future approach to measuring relative skin sensitising potency: a proposal. J Appl Toxicol (2006) 0.81
Aligning the 3Rs with new paradigms in the safety assessment of chemicals. Toxicology (2015) 0.81
Selective haptenation of cellular or extracellular protein by chemical allergens: association with cytokine polarization. Chem Res Toxicol (2005) 0.81
Evaluation of the skin sensitizing potency of chemicals by using the existing methods and considerations of relevance for elicitation. Contact Dermatitis (2005) 0.81
Correction of scaling mismatches in oligonucleotide microarray data. BMC Bioinformatics (2006) 0.80
The safety of genetically modified foods produced through biotechnology. Toxicol Sci (2003) 0.80
Dendritic cells as a tool for the predictive identification of skin sensitisation hazard. Altern Lab Anim (2005) 0.80